产地国家:印度 处方药:是 所属类别:50毫克/片 100片/盒 包装规格:50毫克/片 100片/盒 计价单位:盒 生产厂家中文参考译名: 巴克斯特 生产厂家英文名: Zydus Biogen (Baxter) 原产地英文商品名: Endoxan 50mg/Tablets 100vial/box 原产地英文药品名: Cyclophosphamide 中文参考商品译名: Endoxan 50毫克/片 100片...
所属类别:50毫克/片 100片/盒 包装规格:50毫克/片 100片/盒 计价单位:盒 生产厂家英文名:Zydus Biogen (Baxter) 原产地英文商品名:Endoxan 50mg/Tablets 100vial/box 原产地英文药品名:Cyclophosphamide 中文参考商品译名:Endoxan 50毫克/片 100片/盒 ...
50 mg (of anhydrous cyclophosphamide) Cyclophosphamide Tablets Cytoxan Bristol-Myers Squibb Parenteral For injection 500 mg (of anhydrous cyclophosphamide) Cyclophosphamide for Injection Cytoxan Bristol-Myers Squibb 1 g (of anhydrous cyclophosphamide) Cyclophosphamide for Injection Cytoxan Br...
Cyclophosphamide Tablets, USP are for oral use and contain 25 mg or 50 mg cyclophosphamide (anhydrous). Inactive ingredients in Cyclophosphamide Tablets are: acacia, FD&C Blue No. 1, D&C Yellow No. 10 Aluminum Lake, lactose, magnesium stearate, starch, stearic acid and talc. Uses for Cytoxan ...
Long term survival rates for childhood cancers is steadily increasing, however cancer survivors can experience fertility problems as a consequence of chemotherapy treatment. This is particularly problematic for young boys, for whom no fertility preservat
CYCLOPHOSPHAMIDE IS SUPPLIED AS 25 & 50 MG TABLETS & AS A POWDER (100 TO 2000 MG) IN STERILE VIALS.Grade: USP, measured as containing 95.0 - 105.0% active ingredient calculated as the monohydrate, 5.7 - 6.8% max. water content, 0.002% max. heavy metals, and producing an aqueous solution...
Cyclophosphamidedoi:10.1007/3-540-29668-9_723Cytoxan; Neosar No Alkylating agent; immunosuppressant Cell-cycle nonspecific suppression of B cells and T cells; forms DNA cross-links 25 mg, 50 mg tablets; 100 mg, 200 mg, 300 mg vials for...Springer Berlin Heidelberg...
Furthermore, bortezomib is available in powder form for injection while dexamethasone is available in various tablet doses like 0.25 mg, 0.5 mg, and 1 mg tablets.MorrisonBlountErinBlountK.BlountWaddellBlountJ.BlountAubreyBlountSolimandoBlount
Using various compression forces (0.1 to 6.0 tons), tablet hardness limits of 7.0 SCU to 11.0 SCU, 10.0 SCU to 14.0 SCU and 14.0 SCU to 18.0 SCU for the 25 mg, 50 mg and 100 mg tablets, respectively, will provide acceptable results. Those hardnesses result in acceptable adherence of th...
1. [sic] The invention relates to film-coated tablets with cyclophosphamide as active compound, which in the core comprise cyclophosphamide, one or more fillers, one or m